Acta psychiatrica Scandinavica. Supplementum

How Blocking Noradrenaline and Serotonin Reuptake Relates to Antidepressant Effectiveness

Updated

Abstract

Reboxetine may improve social functioning significantly more than fluoxetine in the treatment of major depression.

  • Numerous studies have compared the efficacy of selective serotonin reuptake inhibitors (SSRIs) and noradrenaline reuptake inhibitors (NRIs) with varied selectivity.
  • Most studies indicate no significant differences in response rates or subtype responsivity between SSRIs and NRIs.
  • Some studies suggest NRIs could be superior to SSRIs in addressing retardation symptoms.
  • SSRIs may be more effective than NRIs for anxiety symptoms.
  • NRIs might be more effective than SSRIs in cases of severe depression.
  • Reboxetine has been shown to be at least as effective as imipramine, desipramine, and fluoxetine.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free